Replies to post #214438 on Biotech Values

[DewDiligence]

TYME PR on converting certain malignant tumors to benign ones raises stock 6%:

https://globenewswire.com/news-release/2017/10/25/1153261/0/en/Tyme-Identifies-Potential-Method-and-Biomarker-for-Converting-Malignant-Tumors-to-Inert-Calcified-Mass.html

Although I don’t follow it closely, this company strikes me as not quite legit.